To determine if diffusion aromatherapy exposure to an essential oil blend can potentially improve mild cognitive impairment/mild dementia symptoms and relieve caregiver stress.
This study also allows us to gauge the willingness of elderly patients in complying with long-term aromatherapy treatments.
Aged 50 years old and above.
Confirmed diagnosis of MCI or mild dementia based on clinical records.
Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to read, understand, and speak the designated language at the study site; either lives with the subject or sees the subject for ≥2 hours/day ≥3 days/week; agrees to accompany the subject to each study visit; and is able to verify daily compliance with study intervention.
Aged 21 years old and above.
Olfactory impaired/dysfunctional.
Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations.
Has Reactive Airway Disease (e.g, Asthma).
Participant without a caregiver.
National Cancer Centre, Singapore
Lead sponsor
Temasek Foundation
Collaborator